<DOC>
	<DOC>NCT01822431</DOC>
	<brief_summary>This study will examine if one of the following methods: pupillometry, spectral analysis of heart rate variability and metaiodobenzylguanidine scintigraphy, is more capable to detect early diabetic autonomic neuropathy in patients with type 1 diabetes mellitus</brief_summary>
	<brief_title>A Comparison Between Pupillometry, Heart Rate Variability and Metaiodobenzylguanidine Scintigraphy for the Diagnosis of Early Diabetic Autonomic Neuropathy in Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>3-Iodobenzylguanidine</mesh_term>
	<criteria>Type 1 diabetes mellitus Type 2 diabetes mellitus Severe cardiac autonomic neuropathy Medications other than insulin Ocular disease other than refractive eye disorders History of neurologic disease History of cardiovascular disease Thyroid disease Vitamin B insufficiency Other possible cause for autonomic failure</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>